| Nutrition and Health in Aging | Lifetime | 37 | IT 3 | 99.76 |
| Frailty in Older Adults | Lifetime | 20 | IT 4 | 99.65 |
| Long-Term Effects of COVID-19 | Lifetime | 82 | IT 18 | 98.98 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 233 | IT 6 | 99.29 |
| Magnesium in Health and Disease | Lifetime | 29 | IT 3 | 98.32 |
| Nutritional Studies and Diet | Lifetime | 259 | IT 10 | 99.03 |
| Diet and metabolism studies | Lifetime | 640 | IT 26 | 98.88 |
| Chronic Disease Management Strategies | Lifetime | 206 | IT 5 | 98.41 |
| Osteoarthritis Treatment and Mechanisms | Lifetime | 298 | IT 7 | 98.57 |
| Inflammatory mediators and NSAID effects | Lifetime | 423 | IT 23 | 97.51 |
| Body Composition Measurement Techniques | Lifetime | 206 | IT 14 | 97.88 |
| Bone health and osteoporosis research | Lifetime | 397 | IT 14 | 98.03 |
| COVID-19 and Mental Health | Lifetime | 890 | IT 69 | 94.70 |
| Health disparities and outcomes | Lifetime | 993 | IT 7 | 96.81 |
| Hip and Femur Fractures | Lifetime | 794 | IT 11 | 96.12 |
| Vitamin D Research Studies | Lifetime | 675 | IT 23 | 95.86 |
| Dietary Effects on Health | Lifetime | 339 | IT 11 | 94.10 |
| Fibromyalgia and Chronic Fatigue Syndrome Research | Lifetime | 857 | IT 23 | 93.81 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 876 | IT 63 | 87.81 |
| Therapeutic Uses of Natural Elements | Lifetime | 641 | IT 61 | 82.34 |
| Nutrition and Health in Aging | 2021-2025 | 1 | IT 1 | 99.87 |
| Frailty in Older Adults | 2021-2025 | 1 | IT 1 | 99.88 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 11 | IT 3 | 99.66 |
| Chronic Disease Management Strategies | 2021-2025 | 13 | IT 1 | 99.03 |
| Long-Term Effects of COVID-19 | 2021-2025 | 54 | IT 8 | 99.11 |
| Bone health and osteoporosis research | 2021-2025 | 12 | IT 2 | 99.14 |
| Nutritional Studies and Diet | 2021-2025 | 55 | IT 8 | 98.71 |
| Diet and metabolism studies | 2021-2025 | 104 | IT 14 | 98.62 |
| Osteoarthritis Treatment and Mechanisms | 2021-2025 | 49 | IT 6 | 98.41 |
| Body Composition Measurement Techniques | 2021-2025 | 33 | IT 7 | 97.52 |
| Magnesium in Health and Disease | 2021-2025 | 7 | IT 3 | 97.39 |
| Inflammatory mediators and NSAID effects | 2021-2025 | 32 | IT 2 | 94.35 |
| Geriatric Care and Nursing Homes | 2021-2025 | 138 | IT 3 | 96.10 |
| Intensive Care Unit Cognitive Disorders | 2021-2025 | 284 | IT 28 | 94.98 |
| Dementia and Cognitive Impairment Research | 2021-2025 | 598 | IT 13 | 95.11 |
| Hip and Femur Fractures | 2021-2025 | 265 | IT 9 | 93.52 |
| Parathyroid Disorders and Treatments | 2021-2025 | 224 | IT 38 | 92.55 |
| Health disparities and outcomes | 2021-2025 | 739 | IT 7 | 91.63 |
| Cerebral Palsy and Movement Disorders | 2021-2025 | 384 | IT 42 | 92.10 |
| Influenza Virus Research Studies | 2021-2025 | 446 | IT 24 | 91.17 |
| Bone health and treatments | 2021-2025 | 389 | IT 44 | 84.04 |
| Clinical Nutrition and Gastroenterology | 2021-2025 | 350 | IT 26 | 84.84 |
| Pharmaceutical Practices and Patient Outcomes | 2021-2025 | 738 | IT 17 | 85.78 |
| Dietary Effects on Health | 2021-2025 | 469 | IT 26 | 77.20 |
| Pressure Ulcer Prevention and Management | 2021-2025 | 400 | IT 10 | 74.06 |
| Vitamin D Research Studies | 2021-2025 | 941 | IT 97 | 72.83 |
| Trace Elements in Health | 2021-2025 | 979 | IT 45 | 71.90 |
| Health and Well-being Studies | 2021-2025 | 942 | IT 5 | 68.41 |
| Aluminum toxicity and tolerance in plants and animals | 2021-2025 | 733 | IT 5 | 65.59 |
| Family Caregiving in Mental Illness | 2021-2025 | 579 | IT 14 | 62.26 |
